Corient Private Wealth’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.57M | Sell |
40,538
-1,589
| -4% | -$218K | 0.01% | 731 |
|
|
2025
Q1 | $7.6M | Sell |
42,127
-882
| -2% | -$159K | 0.01% | 573 |
|
|
2024
Q4 | $6.74M | Sell |
43,009
-4,678
| -10% | -$733K | 0.01% | 617 |
|
|
2024
Q3 | $8.68M | Sell |
47,687
-17,313
| -27% | -$3.15M | 0.01% | 581 |
|
|
2024
Q2 | $11.9M | Buy |
65,000
+29,028
| +81% | +$5.33M | 0.02% | 486 |
|
|
2024
Q1 | $6.4M | Buy |
+35,972
| New | +$6.4M | 0.01% | 642 |
|